The tyrosine kinase inhibitor nilotinib is more efficient than mitotane in decreasing cell viability in spheroids prepared from adrenocortical carcinoma cells.

Silveira, Elaine; Cavalcante, Isadora Pontes; Kremer, Jean Lucas; de Mendonça, Pedro Omori Ribeiro; Lotfi, Claudimara Ferini Pacicco

Silveira, Elaine; Cavalcante, Isadora Pontes; Kremer, Jean Lucas; de Mendonça, Pedro Omori Ribeiro; Lotfi, Claudimara Ferini Pacicco.

Afiliação

Silveira E; Department of Anatomy, Institute of Biomedical Science, University of São Paulo, São Paulo, SP Brazil.
Cavalcante IP; Department of Anatomy, Institute of Biomedical Science, University of São Paulo, São Paulo, SP Brazil.
Kremer JL; Department of Anatomy, Institute of Biomedical Science, University of São Paulo, São Paulo, SP Brazil.
de Mendonça POR; Department of Anatomy, Institute of Biomedical Science, University of São Paulo, São Paulo, SP Brazil.
Lotfi CFP; Department of Anatomy, Institute of Biomedical Science, University of São Paulo, São Paulo, SP Brazil.

Cancer Cell Int ; 18: 29, 2018.

Article em En | MEDLINE | ID: mdl-29507530